Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
120 studies found for:    Open Studies | "Anticoagulants"
Show Display Options
Rank Status Study
21 Not yet recruiting Benchmarking an Oral Anticoagulant Treatment Rate in Patients With Nonvalvular Atrial Fibrillation: A Study of Clinical Characteristics With Insight From Patient and Physician Perspectives
Condition: Nonvalvular Atrial Fibrillation
22 Unknown  rFVIIa in ICH in Patients Treated With Anticoagulants or Anti-Platelets
Condition: Intracerebral Hemorrhage
Interventions: Drug: rFVIIa + (vit K in AO patients);   Drug: FFP or aPCC+ vit K in AO treated patients
23 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
Condition: Atrial Fibrillation
Interventions: Drug: Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban;   Drug: Vitamin K antagonist: warfarin, fluindione, acenocoumarol
24 Not yet recruiting Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF)
Condition: Non Valvular Atrial Fibrillation (nv AF)
Interventions: Drug: Non-exposed group;   Drug: Exposed group
25 Recruiting Randomized Trial of COBRA PzF Stenting to Reduce Duration of Triple Therapy
Conditions: Angina, Stable;   Angina, Unstable;   Anticoagulants
Interventions: Device: COBRA PzF;   Device: Drug Eluting Stent
26 Recruiting Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
Condition: Hematoma
Interventions: Drug: Dabigatran;   Drug: Rivaroxaban;   Drug: Apixaban
27 Unknown  Determination of Residual Anticoagulatory Effects of Fondaparinux
Condition: Anticoagulant Prophylaxis/Therapy
28 Recruiting Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
29 Recruiting Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
Condition: DOAC Eligible Subjects
Intervention: Device: TEG6s DOAC Cartridge
30 Recruiting Register for New Oral Anticoagulants
Condition: Anticoagulation Treatment
31 Not yet recruiting Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
Conditions: Cancer;   Venous Thromboembolism;   Deep Vein Thrombosis (DVT);   Pulmonary Embolism (PE);   Blood Clot
Interventions: Drug: Rivaroxaban;   Drug: Apixaban;   Drug: Edoxaban;   Drug: Dabigatran;   Drug: Warfarin;   Drug: Dalteparin;   Drug: Enoxaparin;   Drug: Fondaparinux
32 Recruiting Sequential Expansion of Comparative Effectiveness of Anticoagulants
Condition: Atrial Fibrillation
33 Recruiting PGE1 as Additive Anticoagulant in ECMO-Therapy
Conditions: Respiratory Distress Syndrome, Adult;   Extracorporeal Membrane Oxygenation
Interventions: Drug: Alprostadil;   Drug: 0.9% sodium chloride solution
34 Recruiting ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON)
Condition: Diabetes
Interventions: Drug: Dabigatran;   Drug: Apixaban;   Drug: Rivaroxaban;   Drug: Edoxaban;   Drug: Warfarin;   Drug: Acenocumarole
35 Unknown  Evaluation of Pharmacokinetic and Pharmacodynamic Characteristics of Indobufen, an Anticoagulant Agent
Condition: Healthy
Intervention: Drug: Indobufen
36 Recruiting Treatment of Symptomatic BPH Patients Undergoing Anticoagulant Therapy Using the PlasmaButton Vaporization Electrode
Condition: Benign Prostatic Hyperplasia
37 Recruiting Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
Condition: Atrial High Rate Episodes
Interventions: Drug: Edoxaban;   Drug: ASA
38 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin
39 Unknown  Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists
Conditions: Severe Bleeding;   Urgent Surgery
40 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years